Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-01-01 @ 11:48 PM
Study NCT ID:
NCT00972959
Status:
COMPLETED
Last Update Posted:
2014-08-05
First Post:
2009-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy
Sponsor:
University of Athens
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | multiple myeloma | View |
| None | 1-3 Prior Lines of Therapy | View |
| None | bortezomib (Velcade) | View |
| None | zoledronic acid (Zometa) | View |
| None | Dexamethasone | View |
| None | bone mineral density | View |
| None | bone pain | View |
| None | bone metabolism | View |
| None | osteolytic lesions | View |
| None | DEXA-scans | View |
| None | X-ray radiography | View |